| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $724.0M | -0.8% |
| Gross Profit | $204.5M | -4.0% |
| R&D Expense | $1.0M | -8.1% |
| SG&A Expense | $139.9M | -10.6% |
| Operating Income | $40.6M | +1.9% |
| Pre-tax Income | $22.5M | -7.3% |
| Income Tax | $5.6M | +5.4% |
| Net Income | $16.8M | -11.2% |
| EPS (Basic) | $0.54 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.0M | +52.9% |
| Accounts Receivable | $154.7M | +21.5% |
| Inventory | $14.0M | -3.3% |
| Current Assets | $216.2M | +25.4% |
| Total Assets | $578.8M | +10.7% |
| Current Liabilities | $124.3M | +8.2% |
| Long-term Debt | $178.0M | +4.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $33.0M | -34.2% |
| Capital Expenditures | $24.7M | +37.8% |
| Investing Cash Flow | -$25.1M | -17.6% |
| Financing Cash Flow | -$595K | +97.8% |
| Free Cash Flow | $8.3M | -74.2% |
| -11.5% |
| EPS (Diluted) | $0.53 | -11.7% |
| Total Liabilities |
| $343.1M |
| +5.9% |
| Stockholders' Equity | $235.1M | +18.4% |